DK1867714T3 - 5-fluoruracilresistente bakterier og fremgangsmåde til produktion deraf - Google Patents

5-fluoruracilresistente bakterier og fremgangsmåde til produktion deraf

Info

Publication number
DK1867714T3
DK1867714T3 DK06731050.8T DK06731050T DK1867714T3 DK 1867714 T3 DK1867714 T3 DK 1867714T3 DK 06731050 T DK06731050 T DK 06731050T DK 1867714 T3 DK1867714 T3 DK 1867714T3
Authority
DK
Denmark
Prior art keywords
microorganism
resistant
producing
grow
expressing
Prior art date
Application number
DK06731050.8T
Other languages
English (en)
Inventor
Jun Amano
Yoshinori Hamaji
Minoru Fujimori
Shunichirou Taniguchi
Original Assignee
Anaeropharma Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaeropharma Science Inc filed Critical Anaeropharma Science Inc
Application granted granted Critical
Publication of DK1867714T3 publication Critical patent/DK1867714T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK06731050.8T 2005-04-08 2006-04-04 5-fluoruracilresistente bakterier og fremgangsmåde til produktion deraf DK1867714T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005112557 2005-04-08
PCT/JP2006/307102 WO2006109619A1 (ja) 2005-04-08 2006-04-04 ５－フルオロウラシル耐性菌およびその作製方法

Publications (1)

Publication Number Publication Date
DK1867714T3 true DK1867714T3 (da) 2013-12-09

Family

ID=37086897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06731050.8T DK1867714T3 (da) 2005-04-08 2006-04-04 5-fluoruracilresistente bakterier og fremgangsmåde til produktion deraf

Country Status (10)

Country Link
US (1) US8734779B2 (da)
EP (1) EP1867714B1 (da)
JP (1) JP4945440B2 (da)
KR (1) KR101302088B1 (da)
CN (1) CN101155911B (da)
CA (1) CA2603453C (da)
DK (1) DK1867714T3 (da)
ES (1) ES2438565T3 (da)
PT (1) PT1867714E (da)
WO (1) WO2006109619A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101448940A (zh) 2006-05-24 2009-06-03 阿内罗药物科学株式会社 基因转运载体的制备方法
DK2274422T3 (da) * 2008-04-17 2017-07-03 Anaeropharma Science Inc Ekspressionsvektor
US8338162B2 (en) * 2009-04-17 2012-12-25 Anaeropharma Science, Inc. Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium
KR20170002403A (ko) 2014-05-01 2017-01-06 가부시키가이샤 아네로파마·사이엔스 이종 폴리펩티드 발현 카세트
CZ309218B6 (cs) * 2014-08-26 2022-06-01 Univerzita Palackého v Olomouci Způsob stanovení aktivity enzymů přeměňujících cytosinové deriváty na uracilové deriváty v buňkách a tkáních
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110737A (en) 1988-02-02 2000-08-29 The Regents Of The University Of California Human platelet-derived growth factor receptor, type A
US6190657B1 (en) 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
CA2302866C (en) 1997-09-10 2012-02-21 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
AU7572900A (en) 1999-08-26 2001-03-19 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
JP3642755B2 (ja) 2000-09-21 2005-04-27 純 天野 嫌気性菌を用いた遺伝子治療用医薬
CA2342040C (en) 2000-09-21 2012-07-10 Kyowa Hakko Kogyo Co., Ltd. Anaerobic bacterium as a drug for cancer gene therapy
KR100457879B1 (ko) 2001-02-24 2004-11-18 주식회사 비피도 비피도박테리움 유래 신규 플라스미드, 이를 이용한 재조합 발현 벡터 및 형질전환 방법
JP4356501B2 (ja) 2003-04-25 2009-11-04 チッソ株式会社 難燃性繊維及びそれを用いた繊維成形体

Also Published As

Publication number Publication date
KR20080006583A (ko) 2008-01-16
CA2603453C (en) 2015-01-27
EP1867714A4 (en) 2008-12-31
EP1867714B1 (en) 2013-09-18
EP1867714A1 (en) 2007-12-19
KR101302088B1 (ko) 2013-08-30
CN101155911B (zh) 2015-08-26
PT1867714E (pt) 2013-12-05
US8734779B2 (en) 2014-05-27
JPWO2006109619A1 (ja) 2008-11-06
WO2006109619A1 (ja) 2006-10-19
ES2438565T3 (es) 2014-01-17
CA2603453A1 (en) 2006-10-19
US20090280091A1 (en) 2009-11-12
CN101155911A (zh) 2008-04-02
JP4945440B2 (ja) 2012-06-06

Similar Documents

Publication Publication Date Title
DK1867714T3 (da) 5-fluoruracilresistente bakterier og fremgangsmåde til produktion deraf
Iguchi et al. Stimulation of methanotrophic growth in cocultures by cobalamin excreted by rhizobia
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
BRPI0506369A (pt) microorganismos, e, métodos para produzir um l-aminoácido
BR0102666A (pt) Método para produzir uma substância alvo usando um microorganismo
DK2357226T3 (da) Rationelt udformede meganukleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
EP1931806A4 (en) PKR ACTIVATION BY HYBRIDIZATION CHAIN REACTION
DE602006020335D1 (de) Verwendung von parp-1-hemmern
EA201001280A1 (ru) Селекция организмов, способных сбраживать смешанные субстраты
MX2007006610A (es) Metodo para simplificar acidos nucleicos microbianos por modificacion quimica de citosinas.
MY165570A (en) Inhibitors of poly (adp-ribose) polymerase
NZ584848A (en) Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
MY176918A (en) N- [ (2 ' r) -2' -deoxy-2' -fluoro-2' -methyl-p-phenyl-5' -uridylyl] - l-alanine 1-methylethyl ester and process for its production
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
MX2023001257A (es) Composiciones de edición dependientes de adenosina desaminasa endógena que actúa sobre el ácido ribonucleico y métodos para usarlas.
WO2011022435A3 (en) Biocontrol microorganisms
EA201001266A1 (ru) Эффективные противоопухолевые парамиксовирусы
Nie et al. Nitrous oxide emission potentials of Burkholderia species isolated from the leaves of a boreal peat moss Sphagnum fuscum
WO2007036233A3 (en) Dekkera/brettanomyces cytosine deaminases and their use
EP2042612A3 (en) A novel nucleotide mixture for improved nucleic acid amplification performance
ATE384121T1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
WO2005076984A3 (en) Thymidylate synthase gene and metastasis
WO2005074560A3 (en) Compositions and methods that enhance rna interference
Popova et al. Outcome of allogeneic hematopoietic stem cell transplantation in patients with prior invasive aspergillosis
ATE334209T1 (de) Inaktivierung von genen des mep-wegs